Search research articles
Contact Us
Filters
Showing results (211-220 of 347) with videos related to
Page
of 35
Sort By:
Japanese Journal of Clinical Oncology
|
April 10, 2015
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study
Yisheng Huang, Li Zhang, Yuankai Shi, et al.
Personalized Medicine
|
May 18, 2018
Ventana immunohistochemistry ALK (D5F3) detection of ALK expression in pleural effusion samples of lung adenocarcinoma
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
May 25, 2016
[Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer]
Sheng Yang, Yan Wang, Xingsheng Hu, et al.
Cancer Research
|
September 2, 2008
Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer
Tong Sun, Yifeng Zhou, Ming Yang, et al.
Leukemia Research
|
October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma
Xiaohong Han, Jianfei Wang, Ningning Zhang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Changgong Zhang, Jianhua Chen, Huijuan Wu, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma
Fengyi Zhao, Yan Qin, Jianliang Yang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 24, 2023
MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
Yan Qin, Tian Qiu, Zucheng Xie, et al.
Blood Advances
|
March 26, 2026
Digital Spatial Profiling Uncovers Transcriptomic Features of Distinct Plasma Cell-like Phenotypes in Diffuse Large B-cell Lymphoma
Zucheng Xie, Yan Qin, Xuemin Xue, et al.
Targeted Oncology
|
April 3, 2020
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
Shiyu Jiang, Yan Qin, Lin Gui, et al.
Page
of 35
Search research articles
Search
Showing results (211-220 of 347) with videos related to
Sort By:
Page
of 35
Japanese Journal of Clinical Oncology
|
April 10, 2015
Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study
Yisheng Huang, Li Zhang, Yuankai Shi, et al.
Personalized Medicine
|
May 18, 2018
Ventana immunohistochemistry ALK (D5F3) detection of ALK expression in pleural effusion samples of lung adenocarcinoma
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
May 25, 2016
[Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer]
Sheng Yang, Yan Wang, Xingsheng Hu, et al.
Cancer Research
|
September 2, 2008
Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer
Tong Sun, Yifeng Zhou, Ming Yang, et al.
Leukemia Research
|
October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma
Xiaohong Han, Jianfei Wang, Ningning Zhang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Changgong Zhang, Jianhua Chen, Huijuan Wu, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma
Fengyi Zhao, Yan Qin, Jianliang Yang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 24, 2023
MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
Yan Qin, Tian Qiu, Zucheng Xie, et al.
Blood Advances
|
March 26, 2026
Digital Spatial Profiling Uncovers Transcriptomic Features of Distinct Plasma Cell-like Phenotypes in Diffuse Large B-cell Lymphoma
Zucheng Xie, Yan Qin, Xuemin Xue, et al.
Targeted Oncology
|
April 3, 2020
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
Shiyu Jiang, Yan Qin, Lin Gui, et al.
Page
of 35